Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 7/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 3/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | ACR | P10323 | 1/20 | 0.32 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.31 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL866961 | 1.00 | PPARA (0.34) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL866347 | 1.00 | PPARA (0.34) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL866345 | 1.00 | PPARA (0.34) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL865720 | 0.98 | ABCG2 (0.33) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL866673 | 0.98 | ABCG2 (0.33) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL866671 | 0.98 | ABCG2 (0.33) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL865722 | 0.98 | ABCG2 (0.33) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL866584 | 0.94 | PPARA (0.33) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL865684 | 0.94 | PPARA (0.33) | PPARAABCG2CYP1A1CYP1B1MAOB | |
| SCHEMBL865682 | 0.94 | PPARA (0.33) | PPARAABCG2CYP1A1CYP1B1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104649916-B | Photocrosslinkable materials | 罗利克有限公司 | 2020-12-01 | — | — | CN | claimed |
| CN-107438653-B | Photoalignment composition | 罗利克有限公司 | 2022-01-07 | — | — | CN | disclosed |
| CN-113652167-A | Photoalignment composition | 罗利克有限公司 | 2021-11-16 | — | — | CN | disclosed |
| US-10557085-B2 | Photoalignment composition | ROLIC AG (CH) | 2020-02-11 | — | — | US | disclosed |
| US-20180079961-A1 | PHOTOALIGNMENT COMPOSITION | ROLIC AG (CH) | 2018-03-22 | — | — | US | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| EP-1966119-B1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2016-10-19 | — | — | EP | disclosed |
| WO-2016156079-A1 | PHOTOALIGNMENT COMPOSITION | ROLIC AG (CH) | 2016-10-06 | — | — | WO | disclosed |
| US-8557922-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2013-10-15 | — | — | US | disclosed |
| US-20130004679-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2013-01-03 | — | — | US | disclosed |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2012-03-29 | — | — | US | disclosed |
| EP-2308827-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-13 | — | — | EP | disclosed |
| EP-2308826-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-13 | — | — | EP | disclosed |
| EP-2305631-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| EP-2142957-A1 | METHOD OF UNIFORM AND DEFECT FREE LIQUID CRYSTAL ALIGNING LAYERS | Rolic AG (CH) | 2010-01-13 | — | — | EP | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| WO-2008119449-A1 | METHOD OF UNIFORM AND DEFECT FREE LIQUID CRYSTAL ALIGNING LAYERS | ROLIC AG (CH) | 2008-10-09 | — | — | WO | disclosed |
| EP-1975687-A1 | Method of uniform and defect free liquid crystal aligning layers | Rolic AG (CH) | 2008-10-01 | — | — | EP | disclosed |
| EP-1966119-A1 | PHOTOCROSSLINKABLE MATERIALS | Rolic AG (CH) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007071091-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293888-A1 | Photocrosslinkable Materials | DDC, PARG, ALAD | PPARA 1787/4885ABCG2 4577/4885CYP1A1 3056/4885 |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | PPARA 1787/4885ABCG2 4577/4885CYP1A1 3056/4885 |
| US-20130004679-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | PPARA 1787/4885ABCG2 4577/4885CYP1A1 3056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.